Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AxiCorp Pharma is a leading German pharmaceutical company specializing in the parallel import of EU-branded pharmaceuticals and the distribution of high-quality generics and biosimilars. Founded in 2002 and headquartered in Friedrichsdorf, the company focuses on providing cost-effective medication across various therapeutic areas, including oncology, HIV, and neurology. AxiCorp operates as a key subsidiary of Dermapharm Holding SE, leveraging a robust supply chain to bridge price differences within the European Union. Their business model emphasizes affordability and accessibility of essential medicines for the German healthcare market. The company also maintains a specialized division, axicorp biotechs, which focuses on the distribution of complex biopharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on axicorp Pharma.